HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
GOSR2
golgi SNAP receptor complex member 2
Chromosome 17 Β· 17q21.32
NCBI Gene: 9570Ensembl: ENSG00000108433.17HGNC: HGNC:4431UniProt: A0A1W2PPP5
79PubMed Papers
22Diseases
0Drugs
27Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneTransporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
membraneintra-Golgi vesicle-mediated transportGolgi apparatusendoplasmic reticulum to Golgi vesicle-mediated transportprogressive myoclonic epilepsy type 6Progressive myoclonic epilepsymuscular dystrophy, congenital, with or without seizuresneurodegenerative disease
✦AI Summary

GOSR2 encodes Membrin, a cis-Golgi SNARE protein essential for intra-Golgi vesicle transport and ER-to-Golgi protein trafficking 1. The protein functions as a t-SNARE that mediates fusion between COPII vesicles budding from the endoplasmic reticulum and the cis-Golgi membrane, enabling cargo delivery through the secretory pathway 1. Pathogenic biallelic GOSR2 mutations cause primarily neurological disease through loss of function, preventing proper GOSR2 localization to the cis-Golgi 2. The expanded phenotypic spectrum includes progressive myoclonus epilepsy (PME), progressive myoclonus ataxia (PMA), congenital muscular dystrophy, and hearing loss 3. The original homozygous founder mutation (c.430G>T; p.Gly144Trp) causes North Sea-PME with early-onset ataxia, areflexia, action myoclonus, and seizures 2. Emerging evidence demonstrates that GOSR2 mutations associate with hypoglycosylation of Ξ±-dystroglycan in muscular dystrophy, linking membrane trafficking dysfunction to dystroglycanopathy 4. Phenotypic severity correlates with specific isoform involvement and mutation type 3. Additionally, genome-wide association studies identified GOSR2 variants associated with anomalies of thoracic arteries and veins during cardiac development 5 and with blood pressure regulation 6, suggesting roles beyond neurological disease.

Sources cited
1
GOSR2 encodes Membrin, a cis-Golgi t-SNARE protein that drives fusion of ER-derived COPII vesicles with the cis-Golgi during ER-to-Golgi transport
PMID: 30954670
2
GOSR2 mutations cause PME through loss of function resulting in failure of GOSR2 protein localization to the cis-Golgi, presenting with early-onset ataxia, myoclonus, and seizures
PMID: 27618868
3
GOSR2 mutations show expanded phenotypic spectrum including PME, PMA, congenital muscular dystrophy, and hearing loss; phenotypic variability relates to mutation severity and isoform involvement
PMID: 41261947
4
GOSR2 mutations associate with Ξ±-dystroglycan hypoglycosylation and congenital muscular dystrophy
PMID: 29855340
5
GOSR2 variants on chromosome 17q21.32 are associated with anomalies of thoracic arteries and veins during cardiac development
PMID: 33201861
6
GOSR2 is implicated in blood pressure regulation through genome-wide association studies
PMID: 21909115
7
GOSR2 mutations identified in progressive myoclonus ataxia cohort as one of multiple genetic etiologies with variable disease progression
PMID: 38844245
Disease Associationsβ“˜22
progressive myoclonic epilepsy type 6Open Targets
0.76Strong
Progressive myoclonic epilepsyOpen Targets
0.70Moderate
muscular dystrophy, congenital, with or without seizuresOpen Targets
0.69Moderate
neurodegenerative diseaseOpen Targets
0.53Moderate
genetic disorderOpen Targets
0.50Moderate
hypertensionOpen Targets
0.47Moderate
atrial fibrillationOpen Targets
0.44Moderate
coronary artery diseaseOpen Targets
0.44Moderate
progressive myoclonus epilepsyOpen Targets
0.38Weak
cardiovascular diseaseOpen Targets
0.37Weak
Increased blood pressureOpen Targets
0.36Weak
essential hypertensionOpen Targets
0.34Weak
atrial flutterOpen Targets
0.34Weak
heart failureOpen Targets
0.34Weak
alcohol drinkingOpen Targets
0.34Weak
Phenotypic abnormalityOpen Targets
0.29Weak
deafnessOpen Targets
0.27Weak
hearing loss, autosomal recessiveOpen Targets
0.27Weak
kidney failureOpen Targets
0.26Weak
cleft lipOpen Targets
0.25Weak
Epilepsy, progressive myoclonic 6UniProt
Muscular dystrophy, congenital, with or without seizuresUniProt
Pathogenic Variants27
NM_004287.5(GOSR2):c.22dup (p.Thr8fs)Pathogenic
Progressive myoclonic epilepsy|Muscular dystrophy|Inborn genetic diseases|not provided|GOSR2-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 8
NM_004287.5(GOSR2):c.336+1G>APathogenic
Progressive myoclonic epilepsy type 6|not provided|Progressive myoclonic epilepsy|Inborn genetic diseases|Muscular dystrophy, congenital, with or without seizures|GOSR2-related disorder|Colon adenocarcinoma
β˜…β˜…β˜†β˜†2026
NM_004287.5(GOSR2):c.430G>T (p.Gly144Trp)Pathogenic
Progressive myoclonic epilepsy type 6|Muscular dystrophy|not provided|Progressive myoclonic epilepsy|Muscular dystrophy, congenital, with or without seizures|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 144
NM_004287.5(GOSR2):c.184A>T (p.Lys62Ter)Pathogenic
Progressive myoclonic epilepsy|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 62
NM_004287.5(GOSR2):c.341_342del (p.Asp113_Ser114insTer)Pathogenic
Inborn genetic diseases|Progressive myoclonic epilepsy
β˜…β˜…β˜†β˜†2025β†’ Residue 113
NM_004287.5(GOSR2):c.82C>T (p.Gln28Ter)Pathogenic
not provided|Progressive myoclonic epilepsy|Muscular dystrophy, congenital, with or without seizures
β˜…β˜…β˜†β˜†2022β†’ Residue 28
NM_004287.5(GOSR2):c.2T>C (p.Met1Thr)Likely pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2025β†’ Residue 1
NM_004287.5(GOSR2):c.95-2A>GLikely pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2025
NM_004287.5(GOSR2):c.262del (p.Gln88fs)Pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2025β†’ Residue 88
NM_004287.5(GOSR2):c.2T>G (p.Met1Arg)Pathogenic
Muscular dystrophy, congenital, with or without seizures|not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 1
NM_004287.5(GOSR2):c.179dup (p.Pro60_Asn61insTer)Pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2024β†’ Residue 60
NM_004287.5(GOSR2):c.241C>T (p.Gln81Ter)Pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2024β†’ Residue 81
NM_004287.5(GOSR2):c.89_90del (p.Val30fs)Pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2024β†’ Residue 30
NM_004287.5(GOSR2):c.95-1G>CLikely pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2023
NM_004287.5(GOSR2):c.186_187del (p.Arg63fs)Pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2023β†’ Residue 63
NM_004287.5(GOSR2):c.221dup (p.Tyr75fs)Pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2023β†’ Residue 75
NM_004287.5(GOSR2):c.262C>T (p.Gln88Ter)Pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2023β†’ Residue 88
NM_004287.5(GOSR2):c.1A>C (p.Met1Leu)Likely pathogenic
Hearing loss, autosomal recessive|not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 1
NM_004287.5(GOSR2):c.16C>T (p.Gln6Ter)Pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2022β†’ Residue 6
NM_004287.5(GOSR2):c.337-2A>GLikely pathogenic
Progressive myoclonic epilepsy
β˜…β˜†β˜†β˜†2022
View on ClinVar β†—
Related Genes
GOLGA2Protein interaction100%GOLGB1Protein interaction100%LMAN1Protein interaction100%USO1Protein interaction100%SEC22CProtein interaction100%COG1Protein interaction100%
Tissue Expression6 tissues
Heart
100%
Bone Marrow
50%
Liver
36%
Brain
33%
Ovary
29%
Lung
29%
Gene Interaction Network
Click a node to explore
GOSR2GOLGA2GOLGB1LMAN1USO1SEC22CCOG1
PROTEIN STRUCTURE
Preparing viewer…
PDB3EG9 Β· 3.00 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.27LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.80 [0.52–1.27]
RankingsWhere GOSR2 stands among ~20K protein-coding genes
  • #5,997of 20,598
    Most Researched79
  • #1,902of 5,498
    Most Pathogenic Variants27
  • #13,395of 17,882
    Most Constrained (LOEUF)1.27
Genes detectedGOSR2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Congenital heart disease risk loci identified by genome-wide association study in European patients.
PMID: 33201861
J Clin Invest Β· 2021
1.00
2
The Genotypic and Phenotypic Spectrum of GOSR2 Mutations: Clinical and Pathophysiological Insights.
PMID: 41261947
J Inherit Metab Dis Β· 2025
0.90
3
Mechanisms of Neurological Dysfunction in GOSR2 Progressive Myoclonus Epilepsy, a Golgi SNAREopathy.
PMID: 30954670
Neuroscience Β· 2019
0.80
4
GOSR2: a progressive myoclonus epilepsy gene.
PMID: 27618868
Epileptic Disord Β· 2016
0.70
5
Novel Genetic and Phenotypic Expansion in
PMID: 37895210
Genes (Basel) Β· 2023
0.60